National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  LAD
  LCID
  LCMI
  LHD
  LHBP
  LIG
  LI
  LIP
  LID
   Epidemiology
   Hepatitis Viruses
   Molecular Hepatitis
   Molecular Viral Biology
   Respiratory Viruses
   Picornavirus Replication
  LIR
  LICP
  MVDB
  LMVR
  LMI
  LMM
  LPD
  LPVD
  LVD
  LZP
  PSIIM
  Research Technologies
  Vaccine Research Center
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Infectious Diseases

Epidemiology Section

Yasutaka Hoshino, D.V.M.

Senior Investigator

Description of Research Program


Isolation and serotypic characterization of human and animal rotaviruses.
Rotavirus, a major causative agent of infantile diarrhea, contains two independent outer shell protective antigens (VP4 and VP7) that elicit neutralizing antibodies and induce resistance to infection when used for immunization. Precise analysis is thus needed for a better understanding of rotavirus epidemiology and for formulation of an effective strategy for control of rotavirus disease by immunization. In this project we determine the major antigenic relationships of various rotavirus strains derived from humans and animals.

Cold-adaptation of human rotaviruses. "Cold-adaptation" has been successfully employed by others to select various attenuated candidate human viral vaccine strains including influenza A and B viruses, and parainfluenza type 3. Two human rotavirus cell culture isolates and three human x human hybrid rotaviruses have been successfully adapted to grow at the suboptimal temperatures of 30°C, 28°C, or 26°C. These "cold-adapted" vaccine candidates will be examined for attenuation, ability to stimulate protective antibodies, and protective efficacy in appropriate experimental animals and then eventually in human volunteers.

Genetic studies of rotavirus pathogenesis. The goals of this project are twofold: 1) to identify the viral genes that play a major role in virulence of rotaviruses by using a semi-homologous system of colostrum-deprived gnotobiotic newborn pigs and various reassortants of porcine rotavirus (which causes diarrhea in gnotobiotic piglets during infection) and human rotavirus (which does not induce productive infection or diarrhea in gnotobiotic piglets), and 2) to apply such information to the formulation of a strategy for the development of safe and effective rotavirus vaccines that are of optimal efficacy.

Awards

The 7th Annual Ralston Purina Small Animal Research Award (Virology).

Memberships 

  • Reoviridae Study Group of International Committee on Taxonomy of Viruses
  • American Society for Virology
  • Conference of Research Workers in Animal Disease

Selected Publications

(Search PubMed.)

Hoshino Y, Kapikian AZ. Rotavirus Serotypes: Classification and importance in rotavirus epidemiology, immunity and vaccine development. J Health Popul Nutr. 2000 18(1): 5-14.

Hosino Y, Jones RW, Kapikian AZ. Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain. Archives in Virology. 1998. 143: 1233-1244.

Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3 or 4 specificity. Journal of Medical Virology. 1997. 51: 319-325.

Hoshino Y, Kapikian AZ. Classification of rotavirus VP4 and VP7 serotypes. Archives in Virology. 1996. 12[Supp]: 99-111.

Hoshino Y, Saif LJ, Kang S-Y, Sereno MM, Chen W-K, Kapikian AZ. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus int he gnotobiotic piglet model. Virology. 1995. 209: 274-280.

Hoshino Y, Kapikian AZ, Chanock RM. Selection of cold-adapted (ca) mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro. Journal of Virology. 1994. 68: 7598-7602.

back to top


Contact Info

Yasutaka Hoshino, D.V.M.
E-mail: hoshino@niaid.nih.gov


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in Labs at NIAID
 
Print Icon Print this page
E-mail Icon E-mail this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Contact Info

Yasutaka Hoshino, D.V.M.
E-mail: hoshino@niaid.nih.gov


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)